Methods and compositions utilizing quinazolinones
US7589098B2 · kind B2 · utility
20Cited by
93References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2005 |
| Grant date | Sep 15, 2009 |
| Priority date | — |
| Expiry date | Nov 3, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/91
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Quinazolinones of formulae 1a, 1b, 1c and 1d are disclosed. They are useful for treating cellular proliferative diseases and disorders associated with KSP kinesin activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.